BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30917169)

  • 1. Genistein treatment duration effects biomarkers of cell motility in human prostate.
    Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
    PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
    Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
    J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary genistein inhibits metastasis of human prostate cancer in mice.
    Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC
    Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.
    Lazarevic B; Hammarström C; Yang J; Ramberg H; Diep LM; Karlsen SJ; Kucuk O; Saatcioglu F; Taskèn KA; Svindland A
    Br J Nutr; 2012 Dec; 108(12):2138-47. PubMed ID: 22397815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
    Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
    Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells.
    Craft CS; Xu L; Romero D; Vary CP; Bergan RC
    Mol Pharmacol; 2008 Jan; 73(1):235-42. PubMed ID: 17951357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
    Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
    Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
    Li Y; Che M; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
    Neoplasia; 2004; 6(4):354-63. PubMed ID: 15256057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.
    Grindel B; Li Q; Arnold R; Petros J; Zayzafoon M; Muldoon M; Stave J; Chung LW; Farach-Carson MC
    Oncotarget; 2016 Mar; 7(9):10433-47. PubMed ID: 26862737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
    Xu L; Bergan RC
    Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis.
    Pavese JM; Krishna SN; Bergan RC
    Am J Clin Nutr; 2014 Jul; 100 Suppl 1(1):431S-6S. PubMed ID: 24871471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase
    Waldbillig F; Nitschke K; Abdelhadi A; von Hardenberg J; Nuhn P; Nientiedt M; Weis CA; Michel MS; Erben P; Worst TS
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein.
    Li Y; Sarkar FH
    Cancer Lett; 2002 Dec; 186(2):157-64. PubMed ID: 12213285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
    Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
    Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.
    Li Y; Su J; DingZhang X; Zhang J; Yoshimoto M; Liu S; Bijian K; Gupta A; Squire JA; Alaoui Jamali MA; Bismar TA
    J Pathol; 2011 May; 224(1):90-100. PubMed ID: 21381033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
    Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
    Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
    Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein versus ICI 182, 780: an ally or enemy in metastatic progression of prostate cancer.
    Nakamura H; Wang Y; Xue H; Romanish MT; Mager DL; Helgason CD; Wang Y
    Prostate; 2013 Dec; 73(16):1747-60. PubMed ID: 24038102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.